PAPAVERINE-PHENTOLAMINE 30-1 MG/ML* INJECTABLE — Class II drug recall D-1092-2019
Terminated recall by Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy, reported 2019-04-17, distributed in OR. Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent
| Recall number | D-1092-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy, Corvallis, OR, United States |
| Recall initiated | 2019-02-21 |
| Classified | 2019-04-09 |
| Reported by FDA | 2019-04-17 |
| Terminated | 2020-07-23 |
| Distributed | OR |
| Reason classes | sterility |
Product
PAPAVERINE-PHENTOLAMINE 30-1 MG/ML* INJECTABLE, (a)10ml (b) 9ml, penile injection, Professional Compounding Pharmacy, 996 NW Circle Blvd. #105 Corvallis, OR 97330
Reason for recall
Lack of Processing Controls: Insanitary conditions observed during compounding of sterile drugs during recent FDA Inspection.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1092-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.